Synthesis of nucleobase-functionalized peptides and investigation on their self-assembly properties with mRNA as cargo
Source abstract
Abstract
Non-covalent interactions are crucial in biological systems, e.g. during cell division process, assembly and desassembly of double stranded DNA. Furthermore, interactions between proteins and nucleoacids play important roles during various cell processes. This study focuses on the synthesis and characterization of thymine and lysine-bearing PEG-peptide conjugates, which leverage these interactions for nanoparticle formation. Using solid-phase peptide synthesis (SPPS), we successfully incorporated nucleobases into peptides, enabling complementary base pairing with nucleic acids. The resulting nanoparticles were characterized using transmission electron microscopy (TEM) and dynamic light scattering (DLS), confirming their uniform size and low polydispersity. We investigated the interaction of these nanoparticles with polyA-tail of mRNA. We demonstrated with the example of eGFP-mRNA, effective cellular uptake and transfection capabilities. PEGylated peptide functionalized with 6 Thymine bases, exhibited enhanced stability and transfection efficiency compared to the other variants tested. Cytotoxicity assays indicated favorable biocompatibility across various cell lines. Overall, our findings underscore the potential of nucleopeptides in developing novel gene delivery systems and advancing biotechnological applications.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Supramolecular Self-Assembly in Materials · DNA and Nucleic Acid Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Fraunhofer Institute for Microengineering and Mikrosystems (IMM), Carl-Zeiss-Str. 18-20, 55129 Mainz, Germany
Funding
Bundesministerium für Bildung und Forschung
References (41)
Show source-provided references
1. Meot-Ner · Chem. Rev. · 2005 · 105 · 21310.1021/cr9411785 ↗
2. Sivakova · Chem. Soc. Rev. · 2005 · 34 · 910.1039/b304608g ↗
3. Le · Polymers · 2017 · 9 · 15010.3390/polym9040150 ↗
4. McHale · Macromolecules · 2012 · 45 · 766510.1021/ma300895u ↗
5. Lutz · Macromolecules · 2005 · 38 · 812410.1021/ma051476b ↗
6. Chea · Polym. Chem. · 2022 · 13 · 505810.1039/D2PY00615D ↗
7. Alaee · Gene Ther. · 2014 · 21 · 13910.1038/gt.2013.66 ↗
8. Huang · Mol. Ther. · 2011 · 19 · 38110.1038/mt.2010.266 ↗
9. Yang · Chemistry · 2023 · 5 · 169610.3390/chemistry5030116 ↗
10. Zhang · J. Controlled Release · 2020 · 323 · 20310.1016/j.jconrel.2020.04.026 ↗
11. Midoux · Br. J. Pharmacol. · 2009 · 157 · 16610.1111/j.1476-5381.2009.00288.x ↗
12. Scognamiglio · Molecules · 2021 · 26 · 355810.3390/molecules26123558 ↗
13. Roviello · Arabian J. Chem. · 2020 · 13 · 196610.1016/j.arabjc.2018.02.014 ↗
14. Roviello · J. Med. Chem. · 2011 · 54 · 209510.1021/jm1012769 ↗
15. Giraud · Nanoscale · 2022 · 14 · 490810.1039/D1NR06131C ↗
16. Mercurio · J. Org. Chem. · 2016 · 81 · 1161210.1021/acs.joc.6b01829 ↗
17. Kizzire · Gene Ther. · 2013 · 20 · 40710.1038/gt.2012.47 ↗
18. Kwok · Int. J. Pharm. · 2000 · 203 · 8110.1016/S0378-5173(00)00435-X ↗
19. Khargharia · J. Controlled Release · 2013 · 170 · 32510.1016/j.jconrel.2013.05.024 ↗
20. Allen · Mol. Pharm. · 2018 · 15 · 388110.1021/acs.molpharmaceut.8b00355 ↗
21. Baumhover · Mol. Pharm. · 2015 · 12 · 432110.1021/acs.molpharmaceut.5b00513 ↗
22. Mathew · Gene Ther. · 2020 · 27 · 19610.1038/s41434-019-0117-0 ↗
23. MacCulloch · Org. Biomol. Chem. · 2019 · 17 · 166810.1039/C8OB02436G ↗
24. Gour · Chem. Commun. · 2012 · 48 · 544010.1039/c2cc31458d ↗
25. Daly · Bioconjugate Chem. · 2019 · 30 · 186410.1021/acs.bioconjchem.9b00271 ↗
26. Chotera · Chemistry · 2018 · 24 · 1012810.1002/chem.201800500 ↗
27. Buchberger · J. Am. Chem. Soc. · 2020 · 142 · 140610.1021/jacs.9b11158 ↗
28. Gour · Chem. Commun. · 2014 · 50 · 686310.1039/C4CC02631D ↗
29. Diaferia · Chemistry · 2021 · 27 · 1430710.1002/chem.202102481 ↗
30. Bucci · Sci. Rep. · 2020 · 10 · 1933110.1038/s41598-020-76297-7 ↗
31. Avitabile · Chemistry · 2019 · 25 · 1485010.1002/chem.201902709 ↗
32. Wang · Angew. Chem., Int. Ed. · 2019 · 58 · 1042310.1002/anie.201814552 ↗
33. Tomassi · Bioorg. Med. Chem. · 2018 · 26 · 253910.1016/j.bmc.2018.04.017 ↗
34. Albericio · J. Org. Chem. · 1998 · 63 · 967810.1021/jo980807y ↗
35. Gober · J. Pept. Sci. · 2021 · 27 · e332310.1002/psc.3323 ↗
36. Filippov · Mater. Horiz. · 2023 · 10 · 535410.1039/D3MH00717K ↗
37. Wang · Colloids Surf., A · 2020 · 590 · 12452910.1016/j.colsurfa.2020.124529 ↗
38. Leng · Pharmaceutics · 2023 · 15 · 148210.3390/pharmaceutics15051482 ↗
39. Tarvirdipour · Soft Matter · 2020 · 16 · 167810.1039/C9SM01990A ↗
40. Erazo-Oliveras · Pharmaceuticals · 2012 · 5 · 117710.3390/ph5111177 ↗
41. Adams · N. Engl. J. Med. · 2018 · 379 · 1110.1056/NEJMoa1716153 ↗